8-K - Revolution Medicines, Inc. Warrant | StockGist

Current Report Details

Event Type

Financial Results

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

2.02

Results of Operations and Financial Condition. On February 25, 2026, Revolution Medicines, Inc. (the “Company”) announced its financial results for the year end

Financial Results

9.01

Financial Statements and Exhibits. Exhibit No. Description 99.1 Press Release, dated February 25, 2026 . 104 Cover Page Interactive Data File (embedded within t

Exhibits Only

Source Document

Exhibits (2)

8-K

99.1

EX-99.1